Mira Pharmaceuticals (MIRA) Non-Current Assets (2022 - 2025)
Mira Pharmaceuticals (MIRA) posted Non-Current Assets of $35439.0 for Q4 2025, little changed sequentially from $35439.0 in Q3 2025, and little changed YoY from $35439.0 in Q4 2024.
Mira Pharmaceuticals (MIRA) Non-Current Assets (2022 - 2025) Analysis & Trends
Mira Pharmaceuticals (MIRA) has 4 years of Non-Current Assets data on file, last reported at $35439.0 in Q4 2025.
- Quarterly Non-Current Assets changed 0.0% year-over-year to $35439.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $141756.0 (down 40.9% YoY) and the FY2025 annual result came in at $35439.0, changed 0.0% from the prior year.
- Non-Current Assets steadied at $35439.0 in Q4 2025 per MIRA's latest filing, from $35439.0 in the prior quarter.
- The five-year high for Non-Current Assets was $3.4 million in Q2 2023, with the low at $35439.0 in Q3 2024.
- Average Non-Current Assets over 4 years is $645159.8, with a median of $35439.0 recorded in 2024.
- Year-over-year, Non-Current Assets tumbled 98.8% in 2024 and changed 0.0% in 2025.
- Mira Pharmaceuticals' Non-Current Assets stood at $363669.0 in 2022, then slumped by 79.59% to $74213.0 in 2023, then tumbled by 52.25% to $35439.0 in 2024, then changed by 0.0% to $35439.0 in 2025.
- Business Quant data shows MIRA's Non-Current Assets at $35439.0 in Q4 2025, $35439.0 in Q3 2025, and $35439.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 61.74 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 141.72 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 102.93 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 84.40 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 125.00 Mn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 61.03 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 37.64 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 165.18 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Mira Pharmaceuticals | 22.51 Mn | 11.48 Mn | - | 35,439.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35,439.00 |
| Sep 30, 2025 | 35,439.00 |
| Jun 30, 2025 | 35,439.00 |
| Mar 31, 2025 | 35,439.00 |
| Dec 31, 2024 | 35,439.00 |
| Sep 30, 2024 | 35,439.00 |
| Mar 31, 2024 | 94,760.00 |
| Dec 31, 2023 | 74,213.00 |
| Sep 30, 2023 | 2.95 Mn |
| Jun 30, 2023 | 3.40 Mn |
| Dec 31, 2022 | 363,669.00 |